Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02506283
Other study ID # KEK-ZH-Nr.2015-0113
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2015
Est. completion date May 2019

Study information

Verified date October 2017
Source University of Applied Sciences and Arts of Southern Switzerland
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study investigates the effects of cooling on the recovery and performance characteristic in young healthy subjects. The study is divided in two projects:

Project A: investigates the effects of 20 min. post-exercise cooling on vertical jump performance and delayed onset muscle soreness and rated perceived exertion.

Project B: investigates the effects of 20 min. pre-exercise cooling on maximal voluntary contraction of the right M. quadriceps femoris and delayed onset muscle soreness and rated perceived exertion.


Description:

The aim of this study is to investigate the effects of a 20 min. external cooling application (+8°C ) versus a external thermo neutral application (+32°C) up to 72 hours post application.

The study is divided in two projects:

Project A: This study is focusing on the recovery process after a max. jump performance (3x30 counter movement jumps). Directly after the exercise subjects receive a cooling or thermo-neutral application. Recovery characteristics measured by vertical jump performance (objective) and delayed onset muscle soreness and rated perceived exertion (subjective) are measured in function of time up to 72 hours post cooling intervention.

Project B: This study is focusing on the effect of 20 min. cooling or thermo-neutral application on the M. quadriceps femoris performance (MVC). After the thermo-application, the 60% endurance MVC is measured by means of surface EMG (OT Bioelettronica 10-750 Hz) in a ergometer chair 90° degrees knee flexion (Cor 1 Bioelettronica). Muscle conduction velocity, MVC (objective), delayed onset muscle soreness and rated perceived exertion (subjective) are measured in function of time up to 72 hours post thermo-application.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date May 2019
Est. primary completion date November 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria:

- only healthy young subjects 18-30 years

- no musculoskeletal surgery in trunk and lower extremities

- injury history in trunk and lower extremity for more than one year

- subjects taking anticonceptive medication are allowed to participate

Exclusion Criteria:

- actual injuries or injuries for less than one year in trunk and /or lower extremities

- injury history in trunk and lower extremity for more than one year with complaints

- anxiety of cooling

- subjects on medication

- pace maker

- cardiovascular disease

- pregnancy

- skeletal problems

- appendectomy for less than two years

- Morbus Raynaud syndrome

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Zamar Therapy CT clinic
Zamar Therapy is a certified medical product (directive 93/42/EEC and ISO 134 85:2012) (www.zamarmedical.com)

Locations

Country Name City State
Switzerland SUPSI Landquart GR

Sponsors (4)

Lead Sponsor Collaborator
University of Applied Sciences and Arts of Southern Switzerland THIM - die internationale Hochschule für Physiotherapie, Universiteit Antwerpen, Vrije Universiteit Brussel

Country where clinical trial is conducted

Switzerland, 

References & Publications (8)

Ascensão A, Leite M, Rebelo AN, Magalhäes S, Magalhäes J. Effects of cold water immersion on the recovery of physical performance and muscle damage following a one-off soccer match. J Sports Sci. 2011 Feb;29(3):217-25. doi: 10.1080/02640414.2010.526132. — View Citation

Banfi G, Lombardi G, Colombini A, Melegati G. Whole-body cryotherapy in athletes. Sports Med. 2010 Jun 1;40(6):509-17. doi: 10.2165/11531940-000000000-00000. Review. — View Citation

Barnett A. Using recovery modalities between training sessions in elite athletes: does it help? Sports Med. 2006;36(9):781-96. Review. — View Citation

Bleakley C, McDonough S, Gardner E, Baxter GD, Hopkins JT, Davison GW. Cold-water immersion (cryotherapy) for preventing and treating muscle soreness after exercise. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008262. doi: 10.1002/14651858.CD008262.pub2. — View Citation

Pointon M, Duffield R, Cannon J, Marino FE. Cold application for neuromuscular recovery following intense lower-body exercise. Eur J Appl Physiol. 2011 Dec;111(12):2977-86. doi: 10.1007/s00421-011-1924-1. Epub 2011 Mar 29. — View Citation

Ross ML, Garvican LA, Jeacocke NA, Laursen PB, Abbiss CR, Martin DT, Burke LM. Novel precooling strategy enhances time trial cycling in the heat. Med Sci Sports Exerc. 2011 Jan;43(1):123-33. doi: 10.1249/MSS.0b013e3181e93210. — View Citation

Wegmann M, Faude O, Poppendieck W, Hecksteden A, Fröhlich M, Meyer T. Pre-cooling and sports performance: a meta-analytical review. Sports Med. 2012 Jul 1;42(7):545-64. doi: 10.2165/11630550-000000000-00000. Review. — View Citation

White GE, Wells GD. Cold-water immersion and other forms of cryotherapy: physiological changes potentially affecting recovery from high-intensity exercise. Extrem Physiol Med. 2013 Sep 1;2(1):26. doi: 10.1186/2046-7648-2-26. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The effect of a 20 minute cryotherapy application on vertical jump performance 24 hours post cold application n= 20 subjects for objective recovery. objective recovery: vertical jump performance (best of three in cm. on just jump plate) 24 hours post cold application is evaluated 0-24hours post cold application
Primary The effect of a 20 minute cryotherapy application on vertical jump performance 48 hours post cold application n= 20 subjects for objective recovery. objective recovery: vertical jump performance (best of three in cm. on just jump plate) 48 hours post cold application is evaluated 24-48 hours post cold application
Primary The effect of a 20 minute cryotherapy application on vertical jump performance 72 hours post cold application n= 20 subjects for objective recovery. objective recovery: vertical jump performance (best of three in cm. on just jump plate) 72 hours post cold application is evaluated 48-72 hours post cold application
Primary The effect of a 20 minute cryotherapy application on maximum voluntary contraction 24 hours post cold application n= 20 subjects for objective performance objective performance: maximum voluntary contraction (best of three in Kg) on ergometer chair (Cor1Bioelectronica) and surface EMG (OT Bioellectronica) 24 hours post cold application is evaluated 0-24 hours post cold application
Primary The effect of a 20 minute cryotherapy application on maximum voluntary contraction 48 hours post cold application n= 20 subjects for objective performance objective performance: maximum voluntary contraction (best of three in Kg) on ergometer chair (Cor1Bioelectronica) and surface EMG (OT Bioellectronica) 48 hours post cold application is evaluated 24-48 hours post cold application
Primary The effect of a 20 minute cryotherapy application on maximum voluntary 72 hours post cold application n= 20 subjects for objective performance objective performance: maximum voluntary contraction (best of three in Kg) on ergometer chair (Cor1Bioelectronica) and surface EMG (OT Bioellectronica) 72 hours post cold application is evaluated 48-72 hours post cold application
Secondary The effect of a 20 minute cryotherapy application on delayed onset muscle soreness 24 hours post cold application n= 20 subjects for subjective recovery. subjective recovery: delayed onset muscle soreness (V.A.S 0-10 cm) 24 hours post cold application is evaluated 0-24 hours post cold application
Secondary The effect of a 20 minute cryotherapy application on delayed onset muscle soreness 48 hours post cold application n= 20 subjects for subjective recovery. subjective recovery: delayed onset muscle soreness (V.A.S 0-10 cm) 48 hours post cold application is evaluated 24-48 hours post cold application
Secondary The effect of a 20 minute cryotherapy application on delayed onset muscle 72 hours post cold application n= 20 subjects for subjective recovery. subjective recovery: delayed onset muscle soreness (V.A.S 0-10 cm) 72 hours post cold application is evaluated 48-72 hours post cold application
Secondary The effect of a 20 minute cryotherapy application on rated perceived exertion 24 hours post cold application n= 20 subjects for subjective recovery. subjective recovery: rated perceived exertion (Borg scale 6-20) 24 hours post cold application is evaluated 0-24 hours post cold application
Secondary The effect of a 20 minute cryotherapy application on rated perceived exertion 48 hours post cold application n= 20 subjects for subjective recovery. subjective recovery: rated perceived exertion (Borg scale 6-20) 48 hours post cold application is evaluated 24-48 hours post cold application
Secondary The effect of a 20 minute cryotherapy application on rated perceived exertion 72 hours post cold application n= 20 subjects for subjective recovery. subjective recovery: rated perceived exertion (Borg scale 6-20) 72 hours post cold application is evaluated 48-72 hours post cold application
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1

External Links